FdaApplication

NDA 208745

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSALIX PHARMACEUTICALS INC
application_typeNDA
approval_date2017-01-19

Products (1)

ProductActive ingredientStrengthDosage form
TRULANCEPLECANATIDE3MGTABLET;ORAL

1 product